Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    -6.50 (-5.42%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Positive test results for encapsulation technology

9 Apr 2013 07:00

RNS Number : 8485B
Revolymer PLC
09 April 2013
Β 

ο»Ώ

9 April 2013

Revolymer plc

Revolymer's REVCAP technology delivers a potential market-breakthrough for domestic mass market liquid laundry detergents

Β 

Revolymer plc ("Revolymer") (AIM: REVO), the British polymer technology company, announces positive results from its latest in-house tests of its proprietary REVCAP encapsulation technology. These results demonstrate both the stabilisation of commercially important bleach actives in domestic mass market liquid laundry detergents, and the subsequent efficient release of such actives in the washing cycle. Accordingly this technology offers the potential for substantial improvement in the performance of domestic mass market liquid laundry products.

The domestic mass market liquid laundry detergent segment continues to grow more rapidly than the conventional powder domestic laundry detergent market. However, current liquid laundry main wash detergents do not contain bleach actives, which are an important constituent of most modern laundry powders and play a key role in cleaning clothes. This is because it has not, to date, been possible to stabilise such actives commonly found in laundry powders in a liquid formulation.

However, Revolymer's REVCAP encapsulation technology creates a water impermeable coating around particles of bleach active that enables them to remain stable within liquid laundry formulations. Once in a washing machine cycle, changes in the environment (e.g. in pH, concentration or ionic strength) trigger the release of the bleach active which can then play its part in cleaning the clothes.

The results from the latest in-house tests on a variety of commercially available domestic mass market liquid laundry detergents to which Revolymer's REVCAP encapsulation technology has been applied show both formulation stability for up to 28 days in accelerated testing, and efficient release of bleach actives in the washing cycle. Accordingly the REVCAP technology is now being progressed into the commercialisation phase, and management are actively working on exploiting the potential to license the technology to appropriate leading players in the market.

Revolymer will present recent underlying data on its REVCAP encapsulation technology at the 46th International Detergency Conference (www.idc.wfk.de) on Tuesday April 9th at 12.30pm at the Hilton Conference Centre, Dusseldorf, Germany; and at the 104th AOCS Annual Meeting & Expo on Tuesday April 30th at 2.40pm at the Palais des congres de Montreal in Montreal, Canada. No new material information will be disclosed at the conferences.

Roger Pettman, Chief Executive of Revolymer said: "Our in-house trials have indicated that Revolymer's REVCAP encapsulation technology achieves the stabilisation of bleach particles in domestic mass market liquid laundry detergents and their efficient release in the cleaning cycle, which could be described as the "holy grail" for detergent manufacturers. Our technology should enable bleach actives to be included in liquid laundry formulations for the first time, dramatically improving the cleaning power of these products in the future. This is a very exciting development for Revolymer and is a great example of how we are delivering our strategy of developing the next generation of polymer-enhanced products for the global FMCG markets."

Dr Paul Armitage, newly appointed VP of Commercial Development at Revolymer said: "We have made significant advances towards optimising our REVCAP encapsulation technology and the latest in-house trials are generating a significant level of interest. Clients are seriously engaging with the market changing potential afforded by the technology and are identifying opportunities for product differentiation with improved commercial value. It seems clear that a domestic mass market liquid laundry product containing REVCAP technology will have a clear competitive advantage over other liquid laundry products currently on the market, in terms of its cleaning power.

Ends

Β 

For further information please contact:

Β 

Revolymer plc

+44 (0) 1244 283 500

Roger Pettman

Rob Cridland

Β 

Β 

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

Β 

Citigate Dewe Rogerson

+44 (0)20 7282 2945

David Dible / Ginny Pulbrook/Malcolm Robertson

Β 

Β 

Β 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the fast moving consumer goods (FMCG) and other industrial markets. Revolymer aims to generate significant and growing high quality revenue streams by licensing its unique technologies to manufacturers and marketers within these markets. Potential applications for the business's technologies are in the household products, personal care and coatings & adhesives product areas (together "Consumer Specialties") and in medicated chewing gum (including nicotine gum) and confectionery chewing gum (together "Gum").

Β 

www.revolymer.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCSSSFMAFDSESL
Date   Source Headline
2nd Jun 20267:00 amRNSMello 2026 Presentation and Update on Trading
1st Jun 20267:00 amRNS-RProgress in Crop Production Field Trials
29th May 20267:00 amRNS-RDevelopment of Next Generation Plant-Based Paints
27th May 20267:00 amRNS-RLaunch of New Marketing Program for Detergents
14th May 20265:55 pmRNSAdjournment of AGM
6th May 20264:46 pmRNSDirector/PDMR Shareholding
27th Apr 20266:16 pmRNSTR-1
23rd Apr 20267:00 amRNSGrants of Options & PDMR dealings
24th Mar 20267:00 amRNSPreliminary Results
28th Jan 20267:00 amRNSTR-1
16th Jan 20265:29 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFull Year Trading Update
15th Sep 20257:00 amRNSHalf Year Results
4th Sep 20257:00 amRNSNotice of Interim Results
27th Aug 20258:19 amRNSTR-1
23rd Jul 20257:00 amRNSH1 2025 Trading Update
16th Jul 20257:00 amRNS-RCroda expands agreement: sustainable odour control
1st Jul 20257:00 amRNS-RCommercial Plant-Based Product Launch
8th May 20252:20 pmRNSResult of AGM
6th May 202512:24 pmRNSTR-1
2nd May 20255:28 pmRNSNotice of AGM
1st May 20257:00 amRNSUpdate on US Tariffs
7th Apr 20257:00 amRNSGrants of Options & PDMR dealings
31st Mar 20257:00 amRNSPreliminary Results
18th Mar 20257:00 amRNSNotice of Results and Company Presentation
22nd Jan 20257:00 amRNSTrading Update
5th Nov 20247:00 amRNSTrading Update
10th Oct 20247:00 amRNSChange of Auditor
10th Sep 20247:00 amRNSHalf Year Results
2nd Sep 20247:00 amRNSNotice of Interim Results, Investor Presentation
16th Jul 20247:00 amRNSH1 2024 Trading Update
20th May 20243:03 pmRNSResult of AGM
20th May 20247:00 amRNSAGM Statement and Trading Update
29th Apr 20247:00 amRNSLaunch of two plant-based performance ingredients
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.